News

How do weight loss drugs like Mounjaro and Wegovy work?
Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...
Weight loss drugs, like Ozempic and Wegovy, are changing lives on Long Island — but at a crushing cost for some
Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...
Regeneron's weight-loss drug helps patients on Wegovy preserve muscle
Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...
Novo Nordisk’s weight loss therapy linked to rare eye disorder, EU panel finds
Novo Nordisk's (NVO) weight loss drug semaglutide (Ozempic, Wegovy, Rybelsus) is linked to a rare eye condition called NAION ...
Hims to cut 4% of workforce amid ban on weight-loss drug copies
Telehealth platform Hims & Hers will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S. ban on ...
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...
Novo Nordisk's Wegovy Tied To Increased Risk Of Rare Vision-Loss Disorder, European Regulators Say
The European Medicines Agency's (EMA) safety committee (PRAC) has concluded its review of medicines containing semaglutide ...
Novo Nordisk's 52% Plunge: Is the Company Fumbling Its Leadership in the $150 Billion Weight Loss Market?
Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...
TipRanks on MSN14h
Novo Nordisk Stock (NVO) Shakes off Links Between Weight Jabs and Vision Loss
Shares in pharmaceuticals group Novo Nordisk (NVO) remained in good shape today despite reports that its weight loss drugs ...
STAT1d
A cautious culture cost Novo Nordisk its lead in the obesity drug race, former employees say
Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...
Why Ozempic maker Novo Nordisk is losing its lead in weight-loss drugs
Novo Nordisk's early lead in weight-loss drugs fades as Eli Lilly surges ahead with more effective therapies and faster ...
Novo Nordisk Stock: Is It Still a Smart Buy?
I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...